COVID-19

COVID-19 Q&A: How will the outbreak impact U.S. pharmaceutical marketing and promotions

2020-05-19T15:03:20+00:00May 19th, 2020|Categories: COVID-19|Tags: |

COVID-19 is impacting the healthcare system in a way we’ve never seen before, and pharmaceutical manufacturers are facing new challenges at rapid speeds. To help keep you informed, we’re releasing a special Q&A series with our experts to discuss the virus’s impact on each stage of the development journey. Today, we spoke with David Ward, Vice President for EHRx Solutions, Sara Stricker, Manager at CEEK [...]

COVID-19 Q&A: How will the outbreak impact small companies

2020-05-18T14:14:46+00:00May 15th, 2020|Categories: COVID-19|Tags: |

Timing Funding PUBLIC FUNDING If a manufacturer has received public funding, they are feeling the effects of the stock market downturn and may need to find ways to decrease budget and/or bring about additional funding sources. PRIVATELY FUNDED If a manufacturer has received funding from private investors, there may be more inherent cash security, but they must [...]

Covid-19 Q&A: How COVID-19 Is impacting State Licensing

2020-04-28T16:45:40+00:00April 28th, 2020|Categories: COVID-19|Tags: |

COVID-19 is impacting the healthcare system in a way we’ve never seen before, and pharmaceutical manufacturers are facing new challenges at rapid speeds. To help keep you informed, we’re releasing a special Q&A series with our experts to discuss the virus’s impact on each stage of the launch journey. Today, we spoke with Vice President of PharmaLicense Ryan Fields about the effect of COVID-19 on state licensing. [...]

Covid-19 Q&A: How Will COVID-19 Impact 3PL Inspections?

2020-04-28T13:57:21+00:00April 22nd, 2020|Categories: COVID-19|Tags: |

COVID-19 is impacting the healthcare system in a way we’ve never seen before, and pharmaceutical manufacturers are facing new challenges at rapid speeds. To help keep you informed, we’re releasing a special Q&A series with our experts to discuss the virus’s impact on each stage of the launch journey. If you’d like to speak with us about how to plan your 3PL inspection process, get in touch. [...]

COVID-19 Q&A: Is Your Clinical Trial On Hold?

2020-04-27T19:32:44+00:00April 14th, 2020|Categories: COVID-19|Tags: |

COVID-19 is impacting the healthcare system in a way we’ve never seen before, and pharmaceutical manufacturers are facing new challenges at rapid speeds. To help keep you informed, we’re releasing a special Q&A series with our experts to discuss the virus’s impact on each stage of the development journey. Let's Talk Posted by: Will Pih EVP of Specialty Commercialization [...]

COVID-19 Vaccine Update

2020-05-18T20:09:04+00:00April 3rd, 2020|Categories: COVID-19|Tags: |

Our team took a look at the most recent pharmaceutical developments from the week, including where we are with treatment options and how manufacturers are racing to find an effective treatment for COVID-19. COVID-19 has had significant effects across the healthcare system There are several vaccines and drug candidates in development which could help prevent or treat COVID-19 VACCINES* [...]

A message regarding COVID-19 and Ongoing work

2020-04-06T23:24:56+00:00March 28th, 2020|Categories: COVID-19|Tags: |

A message regarding COVID-19 and Ongoing work To Our Community, Like many of you, we’ve had to be flexible and responsive during the past couple of weeks and plan to continue doing so as the COVID-19 pandemic unfolds in the weeks and months ahead. We’re currently working remotely to keep our employees, colleagues, and families safe. Being that we already have a large remote team, the transition [...]